576. Half-dose Valganciclovir Prophylaxis is Safe and Cost-effective in CMV Seropositive Renal Transplant Recipients

por shi, yiyun, Rogers, Ralph, Vieira, Kendra, Merhi, Basma, Osband, Adena, Bayliss, George, Gohh, Reginald, Morrissey, Paul, Farmakiotis, Dimitrios
Publicado 2020

530. COVID-19 in kidney transplant recipients: Single-center experience and case-control study

por Hardesty, Anna, Pandita, Aakriti, Shi, Yiyun, Vieira, Kendra, Rogers, Ralph, Merhi, Basma, Osband, Adena, Bayliss, George, Gohh, Reginald, Morrissey, Paul, Beckwith, Curt, Farmakiotis, Dimitrios
Publicado 2020

Coronavirus Disease 2019 in Kidney Transplant Recipients: Single-Center Experience and Case-Control Study

por Hardesty, Anna, Pandita, Aakriti, Vieira, Kendra, Rogers, Ralph, Merhi, Basma, Osband, Adena J., Aridi, Jad, Shi, Yiyun, Bayliss, George, Cosgrove, Christopher, Gohh, Reginald, Morrissey, Paul, Beckwith, Curt G., Farmakiotis, Dimitrios
Publicado 2021